These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14997271)

  • 1. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
    Flory JD; Manuck SB; Perel JM; Muldoon MF
    Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retest reliability of prolactin response to dl-fenfluramine challenge in adults.
    Flory JD; Manuck SB; Muldoon MF
    Neuropsychopharmacology; 2002 Feb; 26(2):269-72. PubMed ID: 11790522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls.
    Anthenelli RM; Maxwell RA
    Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
    Lotrich FE; Bies R; Muldoon MF; Manuck SB; Smith GS; Pollock BG
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
    Lowe SL; Yeo KP; Teng L; Soon DK; Pan A; Wise SD; Peck RW
    Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P; Catapano F; Bortolotti F; Maj M
    Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prolactin response to fenfluramine in impulsive aggression.
    New AS; Trestman RF; Mitropoulou V; Goodman M; Koenigsberg HH; Silverman J; Siever LJ
    J Psychiatr Res; 2004; 38(3):223-30. PubMed ID: 15003426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder.
    Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ
    Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.
    van Amelsvoort TA; Abel KM; Robertson DM; Daly E; Critchley H; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2001 Jul; 26(5):493-502. PubMed ID: 11337133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study.
    Soloff PH; Lynch KG; Moss HB
    Alcohol Clin Exp Res; 2000 Nov; 24(11):1609-19. PubMed ID: 11104107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of age and gender on CNS serotonergic responsivity in normal adults.
    McBride PA; Tierney H; DeMeo M; Chen JS; Mann JJ
    Biol Psychiatry; 1990 May; 27(10):1143-55. PubMed ID: 2340323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
    Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
    Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.